Lenalidomide in myelodysplastic syndromes: Where do we go from here? L. Andres SirulnikRichard M. Stone OriginalPaper 31 January 2008 Pages: 5 - 9
Antiangiogenic therapy in myelodysplastic syndromes: Is there a role? Stephen T. OhJason Gotlib OriginalPaper 31 January 2008 Pages: 10 - 18
Prognosis in myelodysplastic syndromes: Are the new classifications useful? Naomi GaliliAzra Raza OriginalPaper 31 January 2008 Pages: 19 - 22
Immunosuppressive therapy for myelodysplastic syndromes: Refining the indications A. John BarrettElaine M. Sloand OriginalPaper 31 January 2008 Pages: 23 - 28
Diagnosis and management of chronic myelomonocytic leukemia Francesco OnidaMiloslav Beran OriginalPaper 31 January 2008 Pages: 31 - 36
Primary eosinophilic disorders: A concise review Animesh PardananiAyalew Tefferi OriginalPaper 31 January 2008 Pages: 37 - 43
Assessing minimal residual disease in chronic lymphocytic leukemia Andy C. RawstronPeter Hillmen OriginalPaper 31 January 2008 Pages: 47 - 53
Eradication of minimal residual disease in chronic lymphocytic leukemia Carmen Diana SchweighoferMichael HallekClemens-Martin Wendtner OriginalPaper 31 January 2008 Pages: 54 - 60